← Leaderboards
Roland W. Herzog
Indiana University Indianapolis
$25,146,618
Attributed
$39,790,011
Total exposure
18
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$49,940,123 · 19
By mechanism
R01$29,639,015 · 8
P01$17,110,083 · 7
U54$1,387,307 · 1
U01$745,950 · 1
T32$685,616 · 1
R21$372,152 · 1
Top collaborators
- Henry Daniell13 shared
- Arun Srivastava10 shared
- Ype Peter De Jong9 shared
- Sergei Zolotukhin9 shared
- Cornelis P Terhorst8 shared
- Guang-Ping Gao5 shared
- Kam W Leong5 shared
- Dongsheng Duan3 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Randal J. Kaufman$37,816,764
- Michelle L Block$8,185,746
- Matthias Clauss$8,411,925
- Ype Peter De Jong$6,364,069
Others in their field
Top investigators on “Hemophilia A”
- Carol H Miao · Seattle Children'S Hospital$27,105,989
- Mark A Kay · Stanford University$24,062,703
- Timothy Charles Nichols · University Of North Carolina Chapel Hill$19,506,050
- John S. Lollar · Emory University$17,412,316
- Mortimer Poncz · University Of Pennsylvania$14,969,626
- Paul K Whelton · Tulane University Of Louisiana$13,863,648
Research focus
Hemophilia AGene TherapyImmune ResponseLiverProtocols DocumentationImmuneResponseDoseHemophilia BIn VivoBaseImmune ToleranceLinkVectorFactor IxGene TransferHepaticAntigensImmune SystemProteinsTransgenesPreventCellsFactor Viii
Grant awards (92)
Toward Safer Gene Therapy for Hemophilia A$2,542,930
P01 · FY2025 · HL · contact PI
Mechanism of immune response to muscle-directed AAV gene transfer$759,377
R01 · FY2025 · AI · contact PI
Enhancing immune regulation in gene therapy for hemophilia$745,423
R01 · FY2025 · HL · contact PI
Capsid- and genome-modified AAV3 vectors for hemophilia gene therapy.$704,635
R01 · FY2025 · HL
Mechanisms of Innate and Adaptive Immune Responses to AAV-FVIII Gene Transfer$531,904
P01 · FY2025 · HL · contact PI
Administrative Core$103,339
P01 · FY2025 · HL · contact PI
Toward Safer Gene Therapy for Hemophilia A$2,492,072
P01 · FY2024 · HL · contact PI
Mechanism of immune response to muscle-directed AAV gene transfer$759,377
R01 · FY2024 · AI · contact PI
Enhancing immune regulation in gene therapy for hemophilia$704,157
R01 · FY2024 · HL · contact PI
Mechanisms of Innate and Adaptive Immune Responses to AAV-FVIII Gene Transfer$495,271
P01 · FY2024 · HL · contact PI
Basic Sciences Studies on Gene Therapy of Blood Diseases$176,297
T32 · FY2024 · HL · contact PI
Administrative Core$101,509
P01 · FY2024 · HL · contact PI
Toward Safer Gene Therapy for Hemophilia A$2,542,930
P01 · FY2023 · HL · contact PI
Mechanism of immune response to muscle-directed AAV gene transfer$774,002
R01 · FY2023 · AI · contact PI
Enhancing immune regulation in gene therapy for hemophilia$724,174
R01 · FY2023 · HL · contact PI
Mechanisms of Innate and Adaptive Immune Responses to AAV-FVIII Gene Transfer$550,302
P01 · FY2023 · HL · contact PI
Basic Sciences Studies on Gene Therapy of Blood Diseases$241,320
T32 · FY2023 · HL · contact PI
Administrative Core$112,786
P01 · FY2023 · HL · contact PI
Toward Safer Gene Therapy for Hemophilia A$2,572,180
P01 · FY2022 · HL · contact PI
Enhancing immune regulation in gene therapy for hemophilia$729,657
R01 · FY2022 · HL · contact PI
Mechanisms of Innate and Adaptive Immune Responses to AAV-FVIII Gene Transfer$554,819
P01 · FY2022 · HL · contact PI
Immunology of factor IX gene transfer to liver$393,750
R01 · FY2022 · AI · contact PI
In Vivo Mechanism of Immune Response to Factor VIII: Project 2$274,989
U54 · FY2022 · HL · contact PI
Basic Sciences Studies on Gene Therapy of Blood Diseases$180,798
T32 · FY2022 · HL · contact PI
Administrative Core$113,993
P01 · FY2022 · HL · contact PI
Enhancing immune regulation in gene therapy for hemophilia$761,303
R01 · FY2021 · HL · contact PI
Immunology of factor IX gene transfer to liver$393,750
R01 · FY2021 · AI · contact PI
In Vivo Mechanism of Immune Response to Factor VIII: Project 2$278,542
U54 · FY2021 · HL · contact PI
Basic Sciences Studies on Gene Therapy of Blood Diseases$87,201
T32 · FY2021 · HL
Oral Tolerance for Hemophilia$746,710
R01 · FY2020 · HL · contact PI
Immunology of factor IX gene transfer to liver$393,750
R01 · FY2020 · AI · contact PI
In Vivo Mechanism of Immune Response to Factor VIII: Project 2$270,920
U54 · FY2020 · HL · contact PI
Oral Tolerance for Hemophilia$779,623
R01 · FY2019 · HL · contact PI
Enhancing immune regulation in gene therapy for hemophilia$696,357
R01 · FY2019 · HL · contact PI
Immunology of factor IX gene transfer to liver$393,750
R01 · FY2019 · AI · contact PI
In Vivo Mechanism of Immune Response to Factor VIII: Project 2$274,708
U54 · FY2019 · HL · contact PI
Next Generation of Recombinant AAV Serotype For Gene Therapy$770,648
R01 · FY2018 · HL
Enhancing immune regulation in gene therapy for hemophilia$708,753
R01 · FY2018 · HL · contact PI
Oral Tolerance for Hemophilia$650,568
R01 · FY2018 · HL · contact PI
In Vivo Mechanism of Immune Response to Factor VIII: Project 2$288,148
U54 · FY2018 · HL · contact PI
Immunology of factor IX gene transfer to liver$229,372
R01 · FY2018 · AI · contact PI
Immunology of factor IX Gene Transfer to Liver$159,160
R01 · FY2018 · AI · contact PI
Next Generation of Recombinant AAV Serotype For Gene Therapy$788,573
R01 · FY2017 · HL · contact PI
Enhancing immune regulation in gene therapy for hemophilia$715,056
R01 · FY2017 · HL · contact PI
Oral Tolerance for Hemophilia$668,425
R01 · FY2017 · HL · contact PI
Immunology of factor IX gene transfer to liver$337,500
R01 · FY2017 · AI · contact PI
Enhancing immune regulation in gene therapy for hemophilia$745,554
R01 · FY2016 · HL · contact PI
Next Generation of Recombinant AAV Serotype For Gene Therapy$622,223
R01 · FY2016 · HL · contact PI
Immunology of factor IX gene transfer to liver$337,500
R01 · FY2016 · AI · contact PI
Next Generation of Recombinant AAV Serotype For Gene Therapy$142,500
R01 · FY2016 · HL · contact PI
Oral Therapy for Hemophilia A$695,103
R01 · FY2015 · HL · contact PI
Next Generation of Recombinant AAV Serotype For Gene Therapy$630,906
R01 · FY2015 · HL · contact PI
Immunology of factor IX gene transfer to liver$337,500
R01 · FY2015 · AI · contact PI
Oral Therapy for Hemophilia A$695,227
R01 · FY2014 · HL · contact PI
Pathways Towards Immune Tolerance To Coagulation Factors$616,377
P01 · FY2014 · HL · contact PI
Oral immune modulatory therapy using antigens bioencapsulated in plant cells$416,573
R01 · FY2014 · HL
Immunology of factor IX gene transfer to liver$336,188
R01 · FY2014 · AI · contact PI
Oral Therapy for Hemophilia A$663,208
R01 · FY2013 · HL · contact PI
Next Generation of Recombinant AAV Serotype Vectors for Gene Therapy$593,093
R01 · FY2013 · HL
Pathways Towards Immune Tolerance To Coagulation Factors$566,147
P01 · FY2013 · HL · contact PI
Oral immune modulatory therapy using antigens bioencapsulated in plant cells$433,499
R01 · FY2013 · HL
Immunology of factor IX gene transfer to liver$315,135
R01 · FY2013 · AI · contact PI
Oral Therapy for Hemophilia A$692,419
R01 · FY2012 · HL · contact PI
Next Generation of Recombinant AAV Serotype Vectors for Gene Therapy$613,662
R01 · FY2012 · HL
Pathways Towards Immune Tolerance To Coagulation Factors$603,294
P01 · FY2012 · HL · contact PI
Oral immune modulatory therapy using antigens bioencapsulated in plant cells$446,064
R01 · FY2012 · HL
Immunology of Factor IX Gene Transfer to Liver$326,329
R01 · FY2012 · AI · contact PI
Oral Therapy for Hemophilia A$715,070
R01 · FY2011 · HL · contact PI
Pathways Towards Immune Tolerance To Coagulation Factors$611,648
P01 · FY2011 · HL · contact PI
Next Generation of Recombinant AAV Serotype Vectors for Gene Therapy$597,388
R01 · FY2011 · HL
Oral immune modulatory therapy using antigens bioencapsulated in plant cells$458,202
R01 · FY2011 · HL
Immunology of Factor IX Gene Transfer to Liver$323,609
R01 · FY2011 · AI · contact PI
Pathways Towards Immune Tolerance To Coagulation Factors$654,455
P01 · FY2010 · HL · contact PI
Next Generation of Recombinant AAV Serotype Vectors for Gene Therapy$633,276
R01 · FY2010 · HL
Immunology of Factor IX Gene Transfer to Liver$294,512
R01 · FY2010 · AI · contact PI
Immunology of Factor IX Gene Transfer to Liver$355,568
R01 · FY2009 · AI · contact PI
IMMUNE$354,931
P01 · FY2009 · HL · contact PI
IMMUNE$334,866
P01 · FY2008 · HL · contact PI
Immunology of Factor IX Gene Transfer to Liver$325,028
R01 · FY2008 · AI · contact PI
Bioencapsulated Factor IX for Oral Tolerance in Hemophilia B$218,175
R21 · FY2008 · HL · contact PI
IMMUNE$330,326
P01 · FY2007 · HL · contact PI
Bioencapsulated Factor IX for Oral Tolerance in Hemophilia B$153,977
R21 · FY2007 · HL · contact PI
IMMUNE$324,004
P01 · FY2006 · HL · contact PI
Immunology of Factor IX Gene Transfer to Liver$248,642
R01 · FY2006 · AI · contact PI
Immunology of Factor IX Gene Transfer to Liver$188,178
R01 · FY2005 · AI
Immunology of Factor IX Gene Transfer to Liver$82,809
R01 · FY2005 · AI
Immunology of Factor IX Gene Transfer to Liver$297,500
R01 · FY2004 · AI
Immunology of Factor IX Gene Transfer to Liver$297,500
R01 · FY2003 · AI
Immunology of Factor IX Gene Transfer to Liver$291,200
R01 · FY2002 · AI
Core--Research grade vector$248,650
U01 · FY2002 · HL
Core--Research grade vector$248,650
U01 · FY2001 · HL
Core--Research grade vector$248,650
U01 · FY2000 · HL